FDA Center for Drug Evaluation & Research Issues Warning Letter to Shimoga Chemicals
July 22, 2026
July 22, 2026
WASHINGTON, July 22 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Shimoga Chemicals from its Center for Drug Evaluation and Research:
* * *
Recipient: Mr. C. Srinivas Rao, Partner, Shimoga Chemicals, W57A, MIDC, Kupwad, Sangli 416436 Maharashtra, India
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
Warning Letter 320-26-101
Dear . . .
* * *
Recipient: Mr. C. Srinivas Rao, Partner, Shimoga Chemicals, W57A, MIDC, Kupwad, Sangli 416436 Maharashtra, India
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
Warning Letter 320-26-101
Dear . . .